Study of NTS-521 for early recovery after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a new medicine called NTS-521 given through an IV. It is for people who recently had a stroke that caused weakness on one side of the body. The trial aims to see if the medicine can help improve recovery after a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke that caused moderate to severe weakness on one side of your body.
- You were independent and could do daily activities without nursing care before your stroke.
- You are between 45 and 80 years old.
- You are able to follow instructions and cooperate with the study.
- You have not had major surgery or serious injury in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether the study medicine (LT3001) is safe and improves outcomes for people with an acute ischemic stroke who are getting a procedure to remove a clot (EVT). It aims to help certain patients who have a specific brain scan pattern soon after stroke symptoms start.
This study tests a structured, fast way of treating people who have a new ischemic stroke (a stroke caused by a blocked blood vessel). It may help because it focuses on getting the right stroke treatments quickly and consistently.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This study tests a neuroprotective treatment (a medication designed to protect brain cells) in patients with acute ischemic stroke—a stroke caused by a blood clot. The goal is to see if the treatment can reduce brain damage and improve recovery when given within 48 hours of stroke symptoms.
This trial tests an investigational drug called LT3001 for people who have had an acute ischemic stroke (a type of stroke caused by a blocked blood vessel in the brain). The drug is given within 24 hours of the stroke to help reduce the damage and improve recovery. Participating could offer access to a new treatment option that may help improve outcomes.
This trial tests a new treatment called NXL-001 for people who have had a stroke affecting movement. The goal is to see if it is safe and if it can help improve motor function. It is for those who still have moderate to severe weakness 2-4 months after their stroke.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.